Synthesis and evaluation of 3'-azido-2',3'-dideoxypurine nucleosides as inhibitors of human immunodeficiency virus.

[1]  J. Mellors,et al.  The 3′-Azido Group Is Not the Primary Determinant of 3′-Azido-3′-deoxythymidine (AZT) Responsible for the Excision Phenotype of AZT-resistant HIV-1* , 2005, Journal of Biological Chemistry.

[2]  R. Sánchez de la Rosa,et al.  Treatment-limiting toxicities associated withnucleoside analogue reverse transcriptase inhibitor therapy: A prospective, observational study. , 2005, Current therapeutic research, clinical and experimental.

[3]  P. Ruane,et al.  New Nucleoside/Nucleotide Backbone Options: A Review of Recent Studies , 2004, Journal of acquired immune deficiency syndromes.

[4]  Aihua Zhou,et al.  Design and synthesis of 3'- and 5'-O-(3-benzenesulfonylfuroxan-4-yl)-2'-deoxyuridines: biological evaluation as hybrid nitric oxide donor-nucleoside anticancer agents. , 2004, Journal of medicinal chemistry.

[5]  R. Hogrefe,et al.  Improved and Reliable Synthesis of 3′‐Azido‐2′,3′‐dideoxyguanosine Derivatives , 2004, Nucleosides, nucleotides & nucleic acids.

[6]  M. Otto,et al.  Antiviral Activities and Cellular Toxicities of Modified 2′,3′-Dideoxy-2′,3′-Didehydrocytidine Analogues , 2002, Antimicrobial Agents and Chemotherapy.

[7]  T. Pathak.  Azidonucleosides: synthesis, reactions, and biological properties. , 2002, Chemical reviews.

[8]  R. Schinazi,et al.  Structure-activity relationships of 2'-fluoro-2',3'-unsaturated D-nucleosides as anti-HIV-1 agents. , 2002, Journal of medicinal chemistry.

[9]  D. Cooper,et al.  Antiretroviral therapy of HIV-1 infection: established treatment strategies and new therapeutic options. , 2000, Current opinion in microbiology.

[10]  D. Richman,et al.  Incidence and impact of resistance against approved antiretroviral drugs , 2000, Reviews in medical virology.

[11]  R. Schinazi,et al.  Mechanistic studies show that (−)‐FTC‐TP is a better inhibitor of HIV‐1 reverse transcriptase than 3TC‐TP , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  S. Short,et al.  2-amino-9-(3-azido-2,3-dideoxy-beta-D-erythro-pentofuranosyl)-6-substituted-9H-purines: synthesis and anti-HIV activity. , 1995, Bioorganic & medicinal chemistry.

[13]  J. Engels,et al.  Synthesis of dinucleotides containing a bridged non-chiral internucleotide 5′- or 3′-phosphoramidate linkage , 1994 .

[14]  R F Schinazi,et al.  Characterization of human immunodeficiency viruses resistant to oxathiolane-cytosine nucleosides , 1993, Antimicrobial Agents and Chemotherapy.

[15]  J. Collins,et al.  Synthesis of 2-amino-9-(3′-azido-2′,3′-dideoxy-beta-D-erythro-pentofuranosyl)-6-methoxy-9H-purine (AzddMAP) and AzddGuo , 1991 .

[16]  R. Schinazi,et al.  Activities of 3'-azido-3'-deoxythymidine nucleotide dimers in primary lymphocytes infected with human immunodeficiency virus type 1 , 1990, Antimicrobial Agents and Chemotherapy.

[17]  E. De Clercq,et al.  Synthesis and antiviral activity of 3'-heterocyclic substituted 3'-deoxythymidines. , 1990, Journal of medicinal chemistry.

[18]  E. De Clercq,et al.  Nucleic acid related compounds. 57. Synthesis, x-ray crystal structure, lipophilic partition properties, and antiretroviral activities of anomeric 3'-azido-2',3'-dideoxy-2,6-diaminopurine ribosides. , 1989, Journal of medicinal chemistry.

[19]  E. De Clercq,et al.  Synthesis and anti-HIV activity of different sugar-modified pyrimidine and purine nucleosides. , 1988, Journal of medicinal chemistry.

[20]  P. Herdewijn,et al.  Synthesis and biological activity of 3'-azido- and 3'-amino substituted nucleoside analogs , 1985 .

[21]  D W Barry,et al.  3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[22]  F. Eckstein,et al.  Synthesis of 3'-azido-2',3'-dideoxyribofuranosylpurines , 1978 .

[23]  P. Herdewijn,et al.  Synthesis of 9-(3-azido-2,3-dideoxy-β-D--pentofuranosyl)-2,6-diaminopurine (AzddDAP) , 1989 .

[24]  P. Herdewijn.  Anchimeric assistance of a 5'-O-carbonyl function for inversion of configuration at the 3'-carbon atom of 2'-deoxyadenosine. Synthesis of 3'-azido-2',3'-dideoxyadenosine and 3'-azido-2',3'-dideoxyinosine , 1988 .